Viewing Study NCT03505320

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:15 AM
Ignite Modification Date: 2025-12-26 @ 3:15 AM
Study NCT ID: NCT03505320
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-20
First Post: 2018-03-29
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer
Sponsor: Astellas Pharma Global Development, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pharmacokinetics of Zolbetuximab View
None Gastric Cancer View
None Gastro-esophageal Junction (GEJ) Cancer View
None Pharmacokinetics of Oxaliplatin View
None Pharmacokinetics of Fluorouracil Bolus (5-FU) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None zolbetuximab View
None oxaliplatin View
None fluorouracil View
None docetaxel View
None claudiximab View
None IMAB362 View
None Gastro-Esophageal Junction cancer View
None locoregional gastric cancer View
None Pembrolizumab View
None Gastric cancer View